Compare CDNA & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | CRTO |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 940.1M |
| IPO Year | 2007 | 2013 |
| Metric | CDNA | CRTO |
|---|---|---|
| Price | $22.23 | $17.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | $28.00 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 582.4K | 372.8K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.95 |
| EPS | 0.05 | ★ 0.15 |
| Revenue | $48,324,000.00 | ★ $2,296,692,000.00 |
| Revenue This Year | $16.01 | N/A |
| Revenue Next Year | $11.31 | $5.54 |
| P/E Ratio | $446.20 | ★ $114.33 |
| Revenue Growth | 18.93 | ★ 27.65 |
| 52 Week Low | $10.96 | $15.58 |
| 52 Week High | $23.24 | $26.98 |
| Indicator | CDNA | CRTO |
|---|---|---|
| Relative Strength Index (RSI) | 62.79 | 46.32 |
| Support Level | $15.80 | $16.98 |
| Resistance Level | $22.89 | $19.98 |
| Average True Range (ATR) | 0.92 | 0.69 |
| MACD | 0.05 | 0.11 |
| Stochastic Oscillator | 89.08 | 41.51 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.